Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
+$30.5M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.9M |
| 3 |
IPHI
INPHI CORPORATION
IPHI
|
+$23.4M |
| 4 |
Bilibili
BILI
|
+$21.7M |
| 5 |
Gaotu Techedu
GOTU
|
+$16.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$89.7M |
| 2 |
Dominion Energy
D
|
+$69.9M |
| 3 |
Cheniere Energy
LNG
|
+$63.1M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$62.8M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$53.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 15.11% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Healthcare | 12.79% |
| 5 | Communication Services | 10.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Pacira BioSciences
PCRX
$983M
| $368K | 0.02% |
+10,967
| New | +$456K |
|
677
Rogers Communications
RCI
$19.6B
| $368K | 0.02% |
+8,851
| New | +$414K |
|
678
Sunrun
RUN
$2.21B
| $367K | 0.02% |
36,300
+16,304
| +82% | +$268K |
|
679
Boyd Gaming
BYD
$5.87B
| $366K | 0.02% |
+25,399
| New | +$651K |
|
680
Hartford Financial Services
HIG
$36.9B
| $366K | 0.02% |
10,400
-12,300
| -54% | -$641K |
|
681
CRISPR Therapeutics
CRSP
$5.75B
| $365K | 0.02% |
+8,600
| New | +$444K |
|
682
Spire
SR
$4.78B
| $365K | 0.02% |
4,900
+516
| +12% | +$41.4K |
|
683
Iovance Biotherapeutics
IOVA
$3.76B
| $363K | 0.02% |
12,135
-214,716
| -95% | -$5.69M |
|
684
Inspire Medical Systems
INSP
$1.8B
| $362K | 0.02% |
+6,000
| New | +$444K |
|
685
Ventas
VTR
$47.7B
| $362K | 0.02% |
13,500
-49,760
| -79% | -$2.47M |
|
686
WEX
WEX
$6.81B
| $361K | 0.02% |
3,456
-75,872
| -96% | -$14.2M |
|
|
PACW
687
DELISTED
PacWest Bancorp
PACW
| $361K | 0.02% |
20,142
+13,368
| +197% | +$419K |
|
|
RDS.A
688
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $361K | 0.02% |
+10,337
| New | +$483K |
|
689
Ross Stores
ROST
$76.7B
| $359K | 0.02% |
4,123
-8,777
| -68% | -$937K |
|
690
VICI Properties
VICI
$29.2B
| $359K | 0.02% |
21,600
-73,400
| -77% | -$1.72M |
|
|
CMA
691
DELISTED
Comerica
CMA
| $358K | 0.02% |
12,208
-38,602
| -76% | -$2.1M |
|
692
ScottsMiracle-Gro
SMG
$3.55B
| $358K | 0.02% |
3,500
+800
| +30% | +$88K |
|
693
CAE Inc
CAE
$8.02B
| $357K | 0.02% |
+28,300
| New | +$715K |
|
694
Chemours
CC
$2.4B
| $357K | 0.02% |
+40,200
| New | +$580K |
|
695
East-West Bancorp
EWBC
$17.8B
| $357K | 0.02% |
13,882
+7,982
| +135% | +$332K |
|
696
Alkermes
ALKS
$8.11B
| $356K | 0.02% |
+24,688
| New | +$441K |
|
697
Erie Indemnity
ERIE
$13.8B
| $356K | 0.02% |
+2,400
| New | +$387K |
|
698
Navient
NAVI
$886M
| $356K | 0.02% |
46,900
-56,706
| -55% | -$677K |
|
|
HI
699
DELISTED
Hillenbrand
HI
| $354K | 0.02% |
18,500
+2,200
| +13% | +$57.2K |
|
|
GRMN
700
Garmin
GRMN
$56.9B
| $352K | 0.02% |
4,700
-2,600
| -36% | -$235K |
|
Similar funds
Steve Schonfeld's Q1 2020 Portfolio in Review
As of Q1 2020, Steve Schonfeld held 1,717 positions worth $1.59B, down 61% from $4.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $1.91B in Q1 2020, closing 624 positions and reducing 338 holdings. Its most notable exit was Vistra, an estimated $89.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt worth $30M.
- Steve Schonfeld's largest Q1 2020 buy was Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt: 3,000,000 shares worth $30M.
- Steve Schonfeld added most to Allergan plc in Q1 2020, an estimated $26.9M increase.
- Steve Schonfeld's biggest Q1 2020 reduction was Cheniere Energy, cutting an estimated $63.1M.
- Steve Schonfeld fully exited Vistra in Q1 2020, selling an estimated $89.7M.
- Steve Schonfeld's ten largest holdings make up 16% of its $1.59B portfolio in Q1 2020.
- Steve Schonfeld opened 455 new positions and closed 624 in Q1 2020.
- Steve Schonfeld's portfolio value fell 61% quarter-over-quarter to $1.59B.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.